We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$2.09M
AUM Growth
-$1.71B
Cap. Flow
+$165M
Cap. Flow %
7,891.97%
Top 10 Hldgs %
17.5%
Holding
608
New
19
Increased
238
Reduced
260
Closed
18

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.16M
2
IBM icon
IBM
IBM
+$7.08M
3
PLD icon
Prologis
PLD
+$6.1M
4
ED icon
Consolidated Edison
ED
+$5.19M
5
CAH icon
Cardinal Health
CAH
+$5.05M

Sector Composition

Rank Sector Weight
1 Real Estate 15.58%
2 Technology 13.6%
3 Healthcare 13.3%
4 Industrials 13.09%
5 Consumer Staples 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
501
Baker Hughes
BKR
$64.4B
$315 0.02%
10,652
+350
+3% +$9.66K
MRVL icon
502
Marvell Technology
MRVL
$201B
$315 0.02%
8,491
-350
-4% -$14.3K
DHI icon
503
D.R. Horton
DHI
$40.9B
$313 0.02%
3,514
+20
+0.6% +$1.6K
PGRE
504
DELISTED
Paramount Group
PGRE
$313 0.02%
52,704
-1,451
-3% -$9.06K
AIV
505
Aimco
AIV
$381M
$311 0.01%
43,720
MRO
506
DELISTED
Marathon Oil Corporation
MRO
$309 0.01%
+11,410
New +$331K
EQH icon
507
Equitable Holdings
EQH
$13.9B
$307 0.01%
+10,696
New +$317K
KHC icon
508
Kraft Heinz
KHC
$28.7B
$307 0.01%
7,553
-330
-4% -$12.5K
DDOG icon
509
Datadog
DDOG
$90B
$305 0.01%
4,152
J icon
510
Jacobs Solutions
J
$17B
$304 0.01%
3,057
-1,699
-36% -$167K
SBAC icon
511
SBA Communications
SBAC
$19.3B
$303 0.01%
1,080
-3,270
-75% -$910K
CSGP icon
512
CoStar Group
CSGP
$12.4B
$302 0.01%
3,910
-180
-4% -$14.1K
TTWO icon
513
Take-Two Interactive
TTWO
$45.6B
$302 0.01%
2,900
-10,140
-78% -$1.1M
RMD icon
514
ResMed
RMD
$32.3B
$299 0.01%
1,437
-70
-5% -$15.4K
ZBH icon
515
Zimmer Biomet
ZBH
$18.2B
$298 0.01%
2,335
-270
-10% -$31.3K
BDN
516
Brandywine Realty Trust
BDN
$541M
$293 0.01%
47,595
TAP icon
517
Molson Coors Class B
TAP
$7.73B
$292 0.01%
5,673
+350
+7% +$18K
PARA
518
DELISTED
Paramount Global Class B
PARA
$290 0.01%
17,162
+150
+0.9% +$2.76K
PPL
519
PPL Corp
PPL
$26.6B
$290 0.01%
9,932
-340
-3% -$9.35K
NTST
520
NETSTREIT Corp
NTST
$2.05B
$284 0.01%
15,509
-1,683
-10% -$31.4K
ZS icon
521
Zscaler
ZS
$28.5B
$283 0.01%
2,527
EMN icon
522
Eastman Chemical
EMN
$8.37B
$282 0.01%
3,465
-90
-3% -$7.25K
GPN icon
523
Global Payments
GPN
$22.4B
$282 0.01%
2,838
-2,683
-49% -$280K
FNF icon
524
Fidelity National Financial
FNF
$12.7B
$279 0.01%
7,408
-952
-11% -$35.7K
ALNY icon
525
Alnylam Pharmaceuticals
ALNY
$29.9B
$278 0.01%
1,170
-50
-4% -$10.7K

Similar funds

Meiji Yasuda Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Meiji Yasuda Asset Management held 608 positions worth $2.09M, down 100% from $1.71B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Meiji Yasuda Asset Management deployed $165M of net new capital in Q4 2022, opening 19 new positions and adding to 238 existing holdings. Its largest new stake was First Horizon: 94,620 shares worth $2.32K.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $3.3M trimmed.

  • Meiji Yasuda Asset Management's largest Q4 2022 buy was First Horizon: 94,620 shares worth $2.32K.
  • Meiji Yasuda Asset Management added most to AbbVie in Q4 2022, an estimated $7.16M increase.
  • Meiji Yasuda Asset Management's biggest Q4 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $3.3M.
  • Meiji Yasuda Asset Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $5.65M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 17% of its $2.09M portfolio in Q4 2022.
  • Meiji Yasuda Asset Management opened 19 new positions and closed 18 in Q4 2022.
  • Meiji Yasuda Asset Management's portfolio value fell 100% quarter-over-quarter to $2.09M.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.